\n \nSupply: \n \nPPI 20 (140?s)? :?Each box contains 10 X 14 capsules in alu-alu blister strips. \n \nPPI 20 (70?s)??? :?Each box contains 5 X 14 capsules in alu-alu blister strips. \n \nPPI 40?????????????? :?Each box contains 4 X 10 capsules in alu-alu blister strips. \n \nPPI IV??????????????? :?Each combipack contains 1 vial of 40 mg lyophilized Omeprazole and? 1? ampoule of 10 ml Water for Injection with a 10 ml sterile disposable syringe. \n \n  \n \nComposition: \n \nPPI 20:?Each capsule contains Omeprazole BP 20 mg as enteric coated pellets. \n \nPPI 40:?Each capsule contains Omeprazole BP 40 mg as enteric coated pellets. \n \nPPI IV:?Each vial contains lyophilized powder of Omeprazole Sodium BP equivalent to 40 mg Omeprazole. \n \n  \n \nIndications: \n \nBenign gastric and duodenal ulcer, heart burn, NSAID-associated complications, peptic ulcer associated with Helicobacter pylori, gastro-esophageal reflux disease, Zollinger-Ellison syndrome, prevention of acid aspiration syndrome, acid related dyspepsia and other hyper acidic complications. \n \n  \n \nDosage and Administration \n \nAdults \nCapsule: \nPPI (Omeprazole) should be taken before meal. \n \n  \n \nBenign gastric and duodenal ulcers:?20 mg once daily for 4 weeks in duodenal ulceration or 8 weeks in gastric ulceration; in severe or recurrent cases increase to 40 mg daily; maintenance for recurrent duodenal ulcer, 20 mg once daily; prevention of relapse in duodenal ulcer : 10 to 20 mg once daily if symptoms return. \n \nHeart burn:?20 mg once daily for 14 days. \n \nNSAID-associated complications:?NSAID-associated duodenal or gastric ulcer & gastro duodenal erosions, 20 mg once daily for 4 weeks, followed by a further 4 weeks if not fully healed; prophylaxis in patients with a history of NSAID-associated duodenal or gastric ulcers, gastro duodenal lesions, or dyspeptic symptoms who require continued NSAID treatment, 20 mg once daily. \n \nFor Peptic ulcer associated with?Helicobacter pylori: \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Age	Dose
Omeprazole (PPI) 20 mg twice daily. \n \nAmoxicillin (MOXILIN) 1 g twice daily. \n \nClarithromycin (CLARICIN) 500 mg twice daily.	? 01-02 weeks
Omeprazole (PPI) 20 mg twice daily. \n \nClarithromycin (CLARICIN) 500 mg twice daily. \n \nMetronidazole (DIROZYL) 400 mg twice daily.	01 week \n \n
Omeprazole (PPI) 20 mg twice daily. \n \nAmoxicillin (MOXILIN) 1 g twice daily. \n \nMetronidazole (DIROZYL) 400 mg twice daily.	?01-02 weeks

\n  \n \nGastro-esophageal reflux disease:?20 mg once daily for 4 weeks, followed by a further 4-8 weeks if not fully healed; 40 mg once daily has been given for 8 weeks in gastro-esophageal reflux disease refractory to other treatment; may be continued at 20 mg once daily. \n \nMaintenance therapy: 10-20 mg once daily. \n \n  \n \nZollinger-Ellison syndrome:?Initially 60 mg (40+20 mg) once daily; usual range 20-120 mg daily (above 80 mg in 2 divided doses). \n \nGastric acid reduction during general anesthesia (prophylaxis of acid aspiration): 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery. \n \n  \n \nAcid related dyspepsia:?10-20 mg once daily for 2-4 weeks according to response. \n \nInjection: \n \nBenign gastric ulcer, duodenal ulcer and gastro-esophageal reflux disease, 40 mg once daily until oral administration is possible, prophylaxis of acid aspiration, 40 mg completed 1 hour before surgery. In patients with Zollinger-Ellison syndrome the recommended initial dose is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided and given twice daily. \n \nMethod of Administration \n \nInjection:?The solution for IV injection is prepared by 10 ml of WFI (provided) adding to the vial. After reconstitution the injection should be given over 5 minutes or at least by 2.5 minutes at a maximum rate of 4 ml per minute. The solution should be used within 4 hours of reconstitution, when stored in original vial in a cool place. The reconstituted solution should not be used if it contains visible particulate matter. \n \nInfusion:?PPI IV infusion 40 mg should be given as an intravenous infusion (over a period of 20-30 minutes or more). The contents of one vial must be dissolved in 100 ml saline for infusion or 100 ml 5% dextrose solution for infusion. The solution should be used within 12 hours when omeprazole is dissolved in saline and within 6 hours when dissolved in 5% dextrose solution. The constituted solution should not be mixed or co-administered in the same infusion set with any other drug. \n \nUse in children \n \nCapsule: \n \nChild over 2 years : Severe ulcerating reflux esophagitis, 0.7-1.4 mg/kg daily for 4-12 weeks; maximum 40 mg daily (to be initiated by hospital physician under close supervision). \n \nInjection: \n \nThere is limited experience of use in children. \n \nElderly \n \nDose adjustment is not required in the elderly. \n \nImpaired renal or hepatic function: Dose adjustment is not required in renal impairment. Patients with severe liver disease should not require more than 20 mg Omeprazole daily. \n \n  \n \nOR, AS DIRECTED BY PHYSICIAN. \n \n